Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Peter Horby

Flu cases may be ‘starting to settle’ in some areas, NHS chief says

Sir Jim Mackey gave evidence to the Health and Social Care Committee.

Evening Standard

Dismay as UK government halts cash for world-renowned Covid programme

Despite its trials saving thousands during the pandemic, funding is being stopped for the groundbreaking UK Recovery programme

The Guardian - UK

Trial to focus on finding treatments for ‘annual scourge’ of influenza

Flu can kill between 290,000 and 650,000 people globally each year, according to the World Health Organisation.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Top scientists warn Brits ‘the next pandemic is coming and we’re not ready’

Experts say Britain is no more prepared for another pandemic as it was three years ago when Covid struck due to defunding of research and dismantling of key services

Daily Mirror

'Flu is back' after Covid pandemic as cases start to rise

People are urged to get their jab

Wales Online

‘Flu is back’ – scientists warn of risk to NHS as data shows early rise in cases

Generally, flu cases go up in December and January but experts have already seen a rise in cases.

The Independent UK

Monkeypox: New treatment trial launched by Covid researchers

‘It’s crucial that we invest in developing, refining and evaluating treatments for this disease’, says chief trial scientist

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Brit scientists launch world first clinical trial to assess monkeypox treatment

The Platinum trial will be the first randomised controlled trial of a treatment for monkeypox in humans in the world

Evening Standard

The inside story of the ground-breaking Covid-19 Recovery trial

When the effectiveness of dexamethasone was first announced, it changed the treatment of the disease overnight, Guilherme Pessoa-Amorim, Leon Peto and Mark Campbell explain how they did it

The Independent UK

Director of new pandemic institute urges government to prepare UK for next outbreak

Professor Sir Peter Horby tells global leaders ‘to put your money where your mouth is’ and invest in pandemic preparedness

The Independent UK

The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases

Guilherme – June 16, 2020. Evening TV news shows across the world were suddenly opening with the result of our research, and rightly so. Dexamethasone was the first drug to be shown to save the lives of people infected with COVID-19. To a young researcher like me, that day felt…

The Conversation

Monkeypox: UK ‘detecting more cases on a daily basis’, says doctor

Monkeypox, which is related to the now eradicated smallpox virus, is endemic in parts of west and central Africa

Evening Standard

Monkeypox could have 'massive impact' on sexual health services, doctor warns

Workers at sexual health clinics could be stretched thin by monkeypox cases.

Daily Record

Monkeypox could have 'massive impact' on sexual health

A top doctor said services dealing with sexual health could be heavily affected due to isolation

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Monkeypox could have ‘massive impact’ on sexual health services, doctor warns

The disease, first found in monkeys, can be transmitted from person to person through close physical contact – including sexual intercourse .

The Guardian - UK

China detects first human case of H3N8 bird flu strain

Experts say widespread transmission of flu in birds is increasing scope for avian viruses to mix and mutate

Benzinga

Eli Lilly's JAK Inhibitor Baricitinib Cuts Death Risk By 13% In COVID-19 Patients

According to a British study, Eli Lilly And Co (NYSE:LLY) and Incyte Corporation's (NASDAQ:INCY) Olumiant (baricitinib) reduced the risk of death in hospitalized COVID-19 patients by 13%. According to a Reuters report, more than 8,000 patients were administered baricitinib in addition to standard of care in the RECOVERY Trial. Results showed that 546 patients…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organisation

198 stories

BBC Radio 4

177 stories

the University of Oxford

the Health and Social Care Committee

20 stories

Glaxo

17 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.